Glatt

The patent application 20240316057 focuses on a pulsatile release formulation for caffeine, designed to control its release profile over a...

Abstract Background: Active pharmaceutical ingredient (API) content is a critical quality attribute (CQA) of amorphous solid dispersions (ASDs) prepared by spraying...

This year´s CPHI Europe happend last week from 8th to 10th October  in Milano at Fiera Milano. . Pharma Excipients...

This poster was presented at the EuPFI 2024 in Rotterdam by Glatt Pharmaceutical Services: Introduction ➢Bitter tasting active pharmaceutical ingredients...

This year CPHI Europe opens its doors in Milano at Fiera Milano. From 8th to 10th October you can have...

Abstract Compaction pressure can induce an undesirable solid-state polymorphic transition in drugs, fragmentation, loss of coated pellet integrity, and the...

Abstract The hybrid modeling strategy which is based on the integration of mechanistic and data-driven models is proposed and applied...

Abstract The bitter drug, warfarin, has a narrow therapeutic index (NTI) and is used in paediatrics and geriatrics. The aim...

An industrial case study of attempting to comply with EU regulation 2022/63 Recently, concerns have been raised about the safety...

This poster was presented at the PBP World Meeting 2024 by Glatt Pharmaceutical Services with the Utrecht Institute for Pharmaceutical...